American Indians are a minority population in the U.S., numbering only about 4.1 million according to year 2000 census figures.1 While most Indians live in cities, a substantial number live in rural settings and earn marginal wages. Although health care is free for Indians, the services tend to be basic and do not include specialized dementia diagnosis and care. Indians are of special interest to the UTSW ADC because of their increasingly high prevalence of obesity, diabetes, hypertension, and cardiovascular disease.2 We have a long-standing relationship with the Choctaw Nation, which covers 15,000 square miles in southeastern Oklahoma, and comprises 80,000 persons. Given our theme of investigating the impact of vascular and inflammatory factors on the onset and course of AD, this is an ideal study population. Over many years, we have developed a strong positive working relationship with these underserved rural minority individuals by providing clinical sen/ices as a quid pro quo for performing research.
The Specific Aims of the Native American Satellite Diagnostic and Treatment Core are: 1. To provide dementia diagnosis and treatment to the Choctaw Nation through in-person visits to Oklahoma and monthly telemedicine clinics staffed by ADC faculty in Dallas and our nurse and clinical educator in Talihina, Oklahoma. 2. To support UT Southwestern investigator-initiated dementia research. We have enabled the conduct of an Alzheimer Association-sponsored investigation of cardiovascular risk factor in Indians with AD. 3. To support telemedicine-based research. We have established the feasibility of telemedicine based clinical care and neuropsychological testing. 4. To support multi-institutional observational studies and clinical trials. We have contributed 40% of the American Indians in the NACC database and have used the NACC database to compare the clinical course of AD in American Indians with that in Caucasians and African Americans.

Public Health Relevance

The development of successful therapies for Alzheimer's disease (AD) will require a thorough understanding of the pathologic mechanisms that contribute to neurodegeneration. Data from epidemiologic and observational studies indicates that vascular and inflammatory pathology contributes to AD. The goal of the UTSW ADC is to identify biomarkers of vascular and inflammatory pathology that will be useful for selection

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
United States
Zip Code
Neu, Scott C; Pa, Judy; Kukull, Walter et al. (2017) Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. JAMA Neurol 74:1178-1189
Alosco, Michael L; Duskin, Jonathan; Besser, Lilah M et al. (2017) Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set. J Alzheimers Dis 57:953-968
Pandya, Seema Y; Lacritz, Laura H; Weiner, Myron F et al. (2017) Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition. Dement Geriatr Cogn Disord 43:204-214
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Jutkowitz, Eric; MacLehose, Richard F; Gaugler, Joseph E et al. (2017) Risk Factors Associated With Cognitive, Functional, and Behavioral Trajectories of Newly Diagnosed Dementia Patients. J Gerontol A Biol Sci Med Sci 72:251-258
Jefferson-George, Kyra S; Wolk, David A; Lee, Edward B et al. (2017) Cognitive decline associated with pathological burden in primary age-related tauopathy. Alzheimers Dement 13:1048-1053
Evers, Bret M; Rodriguez-Navas, Carlos; Tesla, Rachel J et al. (2017) Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency. Cell Rep 20:2565-2574
Qian, Jing; Hyman, Bradley T; Betensky, Rebecca A (2017) Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design. JAMA Neurol 74:540-548
Moga, Daniela C; Taipale, Heidi; Tolppanen, Anna-Maija et al. (2017) A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. Drugs Aging 34:55-65
Devanand, Davangere P; Liu, Xinhua; Brown, Patrick J (2017) Impact of Functional Deficits in Instrumental Activities of Daily Living in Mild Cognitive Impairment: A Clinical Algorithm to Predict Progression to Dementia. Alzheimer Dis Assoc Disord 31:55-61

Showing the most recent 10 out of 342 publications